Bregal et Ardian s’offrent Ennov
Summary
Private equity firms Bregal and Ardian have agreed to acquire Ennov. Ennov develops regulatory, quality, and document-management software for life sciences and pharmaceutical customers. The transaction brings the ISV under PE ownership and aims to support further product investment and international expansion. This deal highlights ongoing private-equity interest in specialized pharma software and may accelerate consolidation in the sector.
Classifications
industries
No industries detected
applications
Data Management
AskAI Classifications
Labels
Life Sciences Software
Regulatory Software
Clinical Trial Management Software
Linked Companies
Ennov Software for Life
$10M to $25M